Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

Background. Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Full description

Bibliographic Details
Main Authors: Schmitz Sandra, Rommel Denis, Michoux Nicolas, Lhommel Renaud, Hanin François-Xavier, Duprez Thierry, Machiels Jean-Pascal
Format: Article
Language:English
Published: Sciendo 2015-03-01
Series:Radiology and Oncology
Subjects:
Online Access:https://doi.org/10.2478/raon-2014-0030
_version_ 1818596996917755904
author Schmitz Sandra
Rommel Denis
Michoux Nicolas
Lhommel Renaud
Hanin François-Xavier
Duprez Thierry
Machiels Jean-Pascal
author_facet Schmitz Sandra
Rommel Denis
Michoux Nicolas
Lhommel Renaud
Hanin François-Xavier
Duprez Thierry
Machiels Jean-Pascal
author_sort Schmitz Sandra
collection DOAJ
description Background. Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated patients with squamous cell carcinoma of the head and neck (SCCHN).
first_indexed 2024-12-16T11:40:47Z
format Article
id doaj.art-f18b23c1dc6a45a18a7cb48288512b75
institution Directory Open Access Journal
issn 1581-3207
language English
last_indexed 2024-12-16T11:40:47Z
publishDate 2015-03-01
publisher Sciendo
record_format Article
series Radiology and Oncology
spelling doaj.art-f18b23c1dc6a45a18a7cb48288512b752022-12-21T22:32:57ZengSciendoRadiology and Oncology1581-32072015-03-01491172510.2478/raon-2014-0030Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neckSchmitz Sandra0Rommel Denis1Michoux Nicolas2Lhommel Renaud3Hanin François-Xavier4Duprez Thierry5Machiels Jean-Pascal6Department of Medical Oncology and Head and Neck Surgery, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, BelgiumDepartment of Medical Imaging and Radiology, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole IMAG), Université Catholique de Louvain, Brussels, BelgiumDepartment of Medical Imaging and Radiology, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole IMAG), Université Catholique de Louvain, Brussels, BelgiumDepartment of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, BelgiumDepartment of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, BelgiumDepartment of Medical Imaging and Radiology, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole IMAG), Université Catholique de Louvain, Brussels, BelgiumDepartment of Medical Oncology and Head and Neck Surgery, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, BelgiumBackground. Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated patients with squamous cell carcinoma of the head and neck (SCCHN).https://doi.org/10.2478/raon-2014-0030cetuximabhead and neck cancerperfusiondce-ct
spellingShingle Schmitz Sandra
Rommel Denis
Michoux Nicolas
Lhommel Renaud
Hanin François-Xavier
Duprez Thierry
Machiels Jean-Pascal
Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
Radiology and Oncology
cetuximab
head and neck cancer
perfusion
dce-ct
title Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
title_full Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
title_fullStr Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
title_full_unstemmed Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
title_short Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
title_sort dynamic contrast enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
topic cetuximab
head and neck cancer
perfusion
dce-ct
url https://doi.org/10.2478/raon-2014-0030
work_keys_str_mv AT schmitzsandra dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT rommeldenis dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT michouxnicolas dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT lhommelrenaud dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT haninfrancoisxavier dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT duprezthierry dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck
AT machielsjeanpascal dynamiccontrastenhancedcomputedtomographytoassessearlyactivityofcetuximabinsquamouscellcarcinomaoftheheadandneck